Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Curie Ahn, Korean physician, scientist, and educator, trained at Seoul National University Hospital also trained at Cincinnati Medical Center. From 2004 to 2012, she served as a president in Transplantation Research Institute in Seoul National University, while serving as a president in Transplantation Center from 2008 as well. Also, she has been serving as a member of the committee and a chief academician in the Korean Transplantation Society as well as a member of the committee and a consultant in National Institute of Health. She set up efficient organ procurement system and facilitated deceased-donor transplantation in Korean society. She served as a chief academician in 12th Asian Xenotransplantation Symposium and since 2013; she has been working as a member of the committee of Asian Xenotransplantation Congress. She even played as an academician in the World Transplant Congress (WTC) 2014 while working as a member of the WTC since 2010.
We have interests in three fields of transplantation researches - basic xenotransplantation research, basic allotransplantation research, translational medicine research. Initially, we studied the role of innate immunity in xenotransplantation. We have focused on xenogeneic islet transplantation researches from 2009, because diabetes is world-wide problem and rejection of islet xenograft is less severe than solid organ xenograft. Recently, we also start research and development of nonhuman primate models in organ transplantation such as heart, kidney. Secondly, we have been interested in the barriers of successful allogeneic transplantation or tolerance induction such as memory T cells and innate immunity including toll-like receptors. We have studied application of regulatory T cells and stem cells to control of these barriers using skin and islet transplantation models together with cellular and molecular immunologic tools. Lastly, in collaboration with Transplantation Center in Seoul National University Hospital, we have studied translational medicine studies bridging basic transplantation immunology to transplantation clinic. We studied impact of innate immunity on kidney transplant patients using genetic polymorphism studies. We also have interest in developing biomarkers for rejection or prognosis of kidney transplant patients. Translational medicine studies for deceased donor management and postoperative complications are also ongoing.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals